CS logo
small CS logo
Duke Comprehensive Cancer Center

Durham, North Carolina, United States
Hospital in Durham, North Carolina
2 Seeley Mudd, 10 Bryan Searle Drive, Durham, NC 27710

About Duke Comprehensive Cancer Center


The Duke Cancer Institute is a National Cancer Institute-designated Comprehensive Cancer Center, research facility, and hospital. The center is part of the Duke University School of Medicine and Duke University Health System located in Durham, North Carolina, United States.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Duke Comprehensive Cancer Center


During the past decade, Duke Comprehensive Cancer Center conducted 162 clinical trials. In the 10-year time frame, 162 clinical trials started and 85 clinical trials were completed, i.e. on average, 52.5% percent of trials that started reached the finish line to date. In the past 5 years, 62 clinical trials started and 37 clinical trials were completed. i.e. 59.7% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer
1993-06-01
Terminated
Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer
1992-05-01
Completed
Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia
1992-05-01
2006-01-01
Completed
134
Surgery With or Without Chemotherapy in Treating Patients With Stage IB Cervical Cancer
1996-12-01
Completed
Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers
1993-09-01
Completed
Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus
1993-12-01
Completed
216
Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer
1994-03-01
2004-08-01
Completed
25
Nutrition Intervention in Treating Women With Breast Cancer
1994-04-01
2006-12-01
Completed
2,500

Rows per page:

1–100 of 589

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Duke Comprehensive Cancer Center" #1 sponsor was "Duke University" with 105 trials, followed by "Alliance for Clinical Trials in Oncology" with 97 trials sponsored, "Children's Oncology Group" with 56 trials sponsored, "Gynecologic Oncology Group" with 55 trials sponsored and "National Cancer Institute (NCI)" with 55 trials sponsored. Other sponsors include 253 different institutions and companies that sponsored additional 149 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Duke Comprehensive Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 348 trials as a collaborator, "Cancer and Leukemia Group B" with 20 trials as a collaborator, "SWOG Cancer Research Network" with 18 trials as a collaborator, "Eastern Cooperative Oncology Group" with 13 trials as a collaborator and "Genentech, Inc." with 10 trials as a collaborator. Other collaborators include 158 different institutions and companies that were collaborators in the rest 101 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Duke Comprehensive Cancer Center


According to Clinical.Site data, the most researched conditions in "Duke Comprehensive Cancer Center" are "Breast Cancer" (56 trials), "Leukemia" (56 trials), "Brain and Central Nervous System Tumors" (52 trials), "Ovarian Cancer" (43 trials) and "Lung Cancer" (41 trials). Many other conditions were trialed in "Duke Comprehensive Cancer Center" in a lesser frequency.

Clinical Trials Intervention Types at Duke Comprehensive Cancer Center


Most popular intervention types in "Duke Comprehensive Cancer Center" are "Drug" (439 trials), "Biological" (136 trials), "Procedure" (102 trials), "Radiation" (91 trials) and "Other" (53 trials). Other intervention types were less common.
The name of intervention was led by "radiation therapy" (59 trials), "cyclophosphamide" (49 trials), "etoposide" (43 trials), "filgrastim" (43 trials) and "cisplatin" (41 trials). Other intervention names were less common.

Clinical Trials Genders at Duke Comprehensive Cancer Center


The vast majority of trials in "Duke Comprehensive Cancer Center" are 456 trials for "All" genders, 105 trials for "Female" genders and 28 trials for "Male" genders.

Clinical Trials Status at Duke Comprehensive Cancer Center


Currently, there are NaN active trials in "Duke Comprehensive Cancer Center". undefined are not yet recruiting, 50 are recruiting, 46 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 386 completed trials in Duke Comprehensive Cancer Center, undefined suspended trials, and 85 terminated clinical trials to date.
Out of the total trials that were conducted in Duke Comprehensive Cancer Center, 161 "Phase 1" clinical trials were conducted, 258 "Phase 2" clinical trials and 135 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 49 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status